Company news
DiaMedica Therapeutics Inc. news in 2022
DiaMedica Therapeutics Inc.'s news releases, calls and decks from 2022, newest first.
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results
November 8, 2022
DiaMedica Therapeutics to Attend the 13th Annual Craig-Hallum Alpha Select Conference November 17, 2022
November 6, 2022
DiaMedica Therapeutics to Present at Credit Suisse 31st Annual Healthcare Conference
October 30, 2022
DiaMedica Therapeutics Provides Update on ReMEDy2 Trial
October 25, 2022
DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations
September 13, 2022
DiaMedica Therapeutics to Present at Lake Street’s 6th Annual Best Ideas Growth Conference
September 5, 2022
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results
August 9, 2022
DiaMedica Therapeutics to Report Second Quarter 2022 Financial Results and Provide a Business Update August 11, 2022
August 3, 2022
DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022
July 31, 2022
DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199
July 5, 2022
DiaMedica Therapeutics to Attend the 19th Annual Craig-Hallum Institutional Investor Conference Wednesday, June 1, 2022
May 24, 2022
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results
May 3, 2022
DiaMedica Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update May 5, 2022
April 27, 2022
DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results
March 13, 2022
DiaMedica Therapeutics to Report Fourth Quarter 2021 Financial Results and Provide a Business Update March 15, 2022
March 7, 2022
DiaMedica Therapeutics Announces Appointment of Dominic Cundari as Chief Commercial Officer
February 1, 2022
DiaMedica Therapeutics to Present Research at International Stroke Conference
January 24, 2022
DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer
January 4, 2022